Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Atherogenic Role Seen for C-Reactive Protein

By Biotechdaily staff writers
Posted on 20 Sep 2002
Investigators have found that C-reactive protein (CRP) binds to oxidized low-density lipoprotein (LDL) and that this interaction may lead to the chronic inflammation and buildup of fatty deposits that characterize atherosclerotic plaques. More...
This finding was reported in the September 9, 2002, online edition of the Proceedings of the National Academy of Sciences.

The study showed that CRP is not merely a marker of future cardiovascular events, but that it actually binds to oxidized LDL and to dying cells. Furthermore, the researchers found that binding to CRP was through phosphocholine, which is exposed on the surface of LDL particles that have been oxidized.

CRP plays an important role in the immune response by removing pathogens, and recently CRP has been reported to be a useful marker for predicting future atherosclerotic cardiovascular events, but the basis for this correlation remains unclear. It may be that when the circulatory system is overloaded with oxidized LDL, binding to CRP causes accumulation of fatty material in macrophages. These macrophages become the "foam cells” that are found in atherosclerotic plaques.

The report's senior author, Dr. Joseph Witztum, professor of medicine at the University of California, San Diego (USA; www.ucsd.edu), pointed out that cholesterol is still a key player in coronary heart disease. He said that CRP may be working in its "correct role” as part of the immune response to the toxic oxidized LDL and may help promote its clearance.

"If you have low levels of LDL, and thus, low levels of oxidized LDL, then CRP may be of benefit,” Dr. Witztum said. "However, when there is an overwhelming accumulation of LDL, and thus oxidized LDL, in its attempt to help clear the toxic particle, the CRP may actually make things worse. It may cause more oxidized LDL to be taken up into macrophage scavenger cells, which in turn cause cholesterol accumulation.”




Related Links:
University of California, San Diego

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.